CBD is widely believed to have healing qualities, and many cannabis companies want to launch food, drinks and cosmetics that contain it, but they need prior approval. The FDA head told a House Appropriations subcommittee that they will form a group of experts to advise him of regulatory options for CBD. CBD in high concentrations would remain a pharmaceutical product, while CBD in a lesser concentration could be added to food or be used as a dietary supplement.